step 10 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial Efficacy and safety of once-weekly

One important rule: never double up on doses

[19] The classical effect of prolonged use both in adult and paediatric population is steatosis

Retatrutide represents the next frontieran incredibly potent option for individuals who hit a weight-loss plateau or require aggressive intervention for severe metabolic disease.

No pharmacologic agent targeting physiologic traits has proven to be sufficiently effective enough to replace standard therapies

Persistent nausea, vomiting, or abdominal pain Chest tightness or difficulty in breathing Dizziness and fainting Increased heartbeat Fatigue Worsening of existing medical conditions Severe skin rashes If you have any of these symptoms that do not seem mild or normal, you should immediately turn to a professional healthcare provider